EU regulator conditionally approves Abbott's purchase of St Jude
Tweet
Share
E-mail
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo
Get Alerts ABT Hot Sheet
Up)Join SI Premium – FREE
BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' (NYSE: ABT) bid for peer St Jude Medical Inc (NYSE: STJ).
Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.
The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."
(Reporting by Gabriela Baczynska)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Lowered to $140 at Barclays
- Caterpillar sees lower second-quarter sales as machinery boom fades
- Newmont beats quarterly profit estimates on higher production
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
